Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

SML3304

Sigma-Aldrich

TP-040n

≥98% (HPLC)

Synonym(s):

4-(4-Methyl-1-piperazinyl)-N-(2-phenylethyl)-2-pyrimidinamine

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C17H23N5
CAS Number:
1201173-75-2
Molecular Weight:
297.40
UNSPSC Code:
12352200
NACRES:
NA.77

Quality Level

100

Assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

CN1CCN(C2=CC=NC(NCCC3=CC=CC=C3)=N2)CC1

InChI

1S/C17H23N5/c1-21-11-13-22(14-12-21)16-8-10-19-17(20-16)18-9-7-15-5-3-2-4-6-15/h2-6,8,10H,7,9,11-14H2,1H3,(H,18,19,20)

InChI key

BNXNWRSVYQHTOH-UHFFFAOYSA-N

Biochem/physiol Actions

Inactive control for TP-040 a brain penetrant, potent and selective inhibitor of O-GlcNAcase (OGA)
TP-040n is an inactive control for TP-040 a brain penetrant, potent and selective inhibitor of O-GlcNAcase (OGA).

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

SML3304-5MG:
SML3304-25MG:
SML3304-BULK:
SML3304-VAR:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Michiko Tawada et al.
Journal of medicinal chemistry, 64(2), 1103-1115 (2021-01-07)
O-GlcNAcase (OGA) has received increasing attention as an attractive therapeutic target for tau-mediated neurodegenerative disorders; however, its role in these pathologies remains unclear. Therefore, potent chemical tools with favorable pharmacokinetic profiles are desirable to characterize this enzyme. Herein, we report

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service